1. Studies on DNA antibodies using DNA labelled with actinomycin D (3H) or dimethyl (3H) sulphate;Carr, R.I.; Koffler, D.; Agnello, V.; Kunkel, H.G.;Clinical and Experimnental Immunology,1969
2. Interferon production in Hodgkin's disease;Chisholm, M.; Cartwright, T.;Clinical and Experimental Immunology,1975
3. Administration of human fibroblast interferon in chronic hepatitis B infection;Desmyter, J.; Ray, M.B.; De Groote, J.; Bradburne, A.F.; Desmet, V.J.; Edy, V.G.; Bissiau, A.; De Somer, P.; Mortelmans, J.;Lancet,1976
4. Effect of human leucocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis;Greenberg, H.B.; Pollard, R.B.; Lutwick, L.I.; Gregory, P.B.; Robinson, W.S.; Merigan, T.C.;New England Journal of Medicine,1976
5. Hybridisation of Dane particle DNA with the free plasma DNA of hepatitis carriers;Hung, P.P.; Mao, J.C.-H.; Ling, C.M.; Overby, L.R.;Nature,1975